Neisseria gonorrhoeae FC428 Subclone, Vietnam, 2019-2020

Insights

A new Neisseria gonorrhoeae subclone (ST-13871) resistant to ceftriaxone and cefixime was found in Vietnam. This emergence poses a significant threat to gonorrhea treatment effectiveness.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Neisseria gonorrhoeae is a major cause of sexually transmitted infections.
  • Antimicrobial resistance in N. gonorrhoeae is a growing global health concern.
  • Effective treatment options for gonorrhea are becoming increasingly limited.

Purpose of the Study:

  • To identify and characterize emerging antimicrobial-resistant Neisseria gonorrhoeae strains in Vietnam.
  • To assess the prevalence of specific resistant subclones.
  • To evaluate the implications for gonorrhea treatment.

Main Methods:

  • Analysis of 114 clinical Neisseria gonorrhoeae isolates collected in Vietnam (2019-2020).
  • Detection of subclone sequence type 13871 within the FC428 clonal complex.
  • Genotypic analysis, including identification of mosaic penA allele 60.001.

Main Results:

  • Fifteen isolates of subclone ST-13871 were identified.
  • Fourteen ST-13871 isolates exhibited nonsusceptibility to ceftriaxone or cefixime due to mosaic penA allele 60.001.
  • Three of these 14 isolates were also nonsusceptible to azithromycin.

Conclusions:

  • The emergence of Neisseria gonorrhoeae subclone ST-13871 in Vietnam is a significant public health concern.
  • This resistant subclone threatens the effectiveness of current gonorrhea treatment regimens.
  • Continued surveillance and antimicrobial resistance monitoring are crucial.